Cardiomyopathy News and Research RSS Feed - Cardiomyopathy News and Research

Cardiomyopathy is a group of diseases with primary, usually diffuse, involvement of the myocardium. The myocardial disease is not secondary to ischaemic, valvular, congenital or pericardial disease.
Genomics testing in action: an interview with Kevin Haar, CEO, Appistry

Genomics testing in action: an interview with Kevin Haar, CEO, Appistry

The more connections are made between genes, disease and drugs, and the more that we continue to understand about those connections, the more critical genetic testing will become in modern medicine. [More]
Encapsula releases 2 new liposome based products

Encapsula releases 2 new liposome based products

Encapsula NanoSciences announces the release of two new liposome ­based products; Curcusome® and Taurosome™. Curcusome® or liposomal curcumin is a nutraceutical supplement that comes innovatively packaged in a powder ­release cap for consumer ease. [More]
New evidence for painless AF treatment to be presented at FCVB 2014

New evidence for painless AF treatment to be presented at FCVB 2014

The first evidence for a shockless treatment for atrial fibrillation (AF) will be presented today at Frontiers in CardioVascular Biology (FCVB) 2014 in Barcelona, Spain. T [More]
Exome sequencing improves diagnosis of mitochondrial disease

Exome sequencing improves diagnosis of mitochondrial disease

Use of exome sequencing improved the ability to identify the underlying gene mutations in patients with biochemically defined defects affecting multiple mitochondrial respiratory chain complexes (enzymes that are involved in basic energy production), according to a study in the July 2 issue of JAMA. [More]
Myosin binding protein C holds the key to new treatments for heart disease

Myosin binding protein C holds the key to new treatments for heart disease

Loyola University Chicago recently hosted a meeting of more than 60 of the world's leading researchers of a protein that could hold the key to new treatments for heart disease. [More]
Alnylam announces new pre-clinical results with DC for ALN-CC5 to treat complement-mediated diseases

Alnylam announces new pre-clinical results with DC for ALN-CC5 to treat complement-mediated diseases

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today new pre-clinical results with its Development Candidate (DC) for ALN-CC5, a subcutaneously administered investigational RNAi therapeutic targeting complement component C5 in development for the treatment of complement-mediated diseases. [More]
Pregnant women with obstructive sleep apnea more likely to die in hospital

Pregnant women with obstructive sleep apnea more likely to die in hospital

Pregnant women with obstructive sleep apnea are more than five times as likely to die in the hospital than those without the sleep disorder, a comprehensive national study by the University of South Florida researchers found. [More]
Loyola offers new type of implantable defibrillator that prevents sudden cardiac death

Loyola offers new type of implantable defibrillator that prevents sudden cardiac death

Loyola University Medical Center has begun offering patients a new type of implantable defibrillator that prevents sudden cardiac death with an electric shock to the heart. [More]
Scientists identify first gene linked to childhood-onset familial dilated cardiomyopathy

Scientists identify first gene linked to childhood-onset familial dilated cardiomyopathy

Scientists at Icahn School of Medicine at Mount Sinai, along with collaborators at institutions in India, Italy, and Japan, have identified the first gene linked to childhood-onset familial dilated cardiomyopathy (DCM), one of the most common heart muscle diseases in children. [More]
Early identification of heart disease a priority for schizophrenia patients

Early identification of heart disease a priority for schizophrenia patients

Early recognition and treatment of coronary artery disease must become a clinical priority for all adults with schizophrenia, say researchers who studied autopsy data for schizophrenia patients who died suddenly in hospital. [More]
tPA therapy improves outcomes for patients suffering acute ischemic stroke

tPA therapy improves outcomes for patients suffering acute ischemic stroke

Administering a clot-dissolving drug to stroke victims quickly — ideally within the first 60 minutes after they arrive at a hospital emergency room — is crucial to saving their lives, preserving their brain function and reducing disability. [More]
MCVI receives federal approval to launch adult heart transplant program at Memorial Regional Hospital

MCVI receives federal approval to launch adult heart transplant program at Memorial Regional Hospital

The Memorial Cardiac and Vascular Institute (MCVI), a leading provider of adult cardiac services in South Florida, has received federal approval from UNOS (United Network for Organ Sharing) to launch an adult heart transplant program at Memorial Regional Hospital in Hollywood. [More]
CardioCell receives IND approval for Phase IIa clinical study of itMSC therapy to treat heart failure

CardioCell receives IND approval for Phase IIa clinical study of itMSC therapy to treat heart failure

CardioCell LLC has just received the FDA's investigational new drug (IND) approval for a United States-based, Phase IIa clinical study using its allogeneic stem-cell therapy to treat subjects with chronic heart failure (CHF), which generates more than 1 million hospitalizations annually. [More]
Managing pregnancy-related complications: an interview with Dr. Mark Zakowski

Managing pregnancy-related complications: an interview with Dr. Mark Zakowski

Pregnancy-related mortality has increased over the last 25 years. Ten years ago the top three pregnancy-related mortality diagnoses were hemorrhage, preeclampsia, and embolism (includes thrombotic and amniotic). [More]
European screening guidelines lead to potential false disqualification of black athletes

European screening guidelines lead to potential false disqualification of black athletes

A new study by researchers at St George's, University of London published in the journal Circulation has found that current European screening guidelines used by sports organisations to detect heart abnormalities lead to over-investigation and potential false disqualification of black athletes with perfectly healthy hearts. [More]
Study of astronauts show heart becomes more spherical when exposed to microgravity in space

Study of astronauts show heart becomes more spherical when exposed to microgravity in space

New findings from a study of 12 astronauts show the heart becomes more spherical when exposed to long periods of microgravity in space, a change that could lead to cardiac problems, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session. [More]

Device to improve blood flow implanted in muscular dystrophy patient

"Today, we're going to make history," said 18-year-old Eric Ramos on the day UT Southwestern Medical Center doctors operated on his ailing heart. [More]

Heart failure patients benefit from new device till transplant

The largest single-center study of patients implanted with a total artificial heart finds the device may help patients in severe heart failure survive until they can receive a heart transplant, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session. [More]
Study links broken heart syndrome to natural disasters

Study links broken heart syndrome to natural disasters

Dramatic spikes in cases of Takotsubo cardiomyopathy, also called broken heart syndrome, were found in two states after major natural disasters, suggesting the stress of disasters as a likely trigger, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session. [More]
Expert highlights the importance of gender-specific approach for treating diabetes mellitus

Expert highlights the importance of gender-specific approach for treating diabetes mellitus

The international guidelines on the drug-based therapy of diabetes mellitus specify which factors need to be taken into account during treatment. [More]